Do very low CD57+ lymphocyte counts indicate chronic Borrelia exposure?

The use of CD57+ lymphocyte counts as a biomarker for chronic Borrelia exposure is a subject of significant debate in clinical immunology, balancing emerging cytotoxic cell research against inconsistent diagnostic data.

Clinical evidence in chronic Borrelia

The association between low CD57+ natural killer (NK) cell counts and chronic Lyme disease stems from observational studies suggesting that patients with persistent symptoms have significantly lower levels of these mature NK cells compared to healthy controls.

• Contradictory findings: While early research (e.g., studies involving approximately 100-200 participants) suggested CD57+ counts could distinguish chronic Lyme from other conditions, subsequent larger evaluations have failed to replicate these results consistently.
• Diagnostic limitations: Major medical organizations, including the IDSA, do not recognize CD57+ counts as a valid diagnostic tool due to a lack of standardization and poor specificity; low counts are also observed in other chronic infections and conditions.

Mechanistic insights into immune surveillance

Biologically, the CD57 marker identifies terminally differentiated, highly mature NK cells. These cells represent the "front line" of the innate immune system's surveillance mechanism.

• Cytolytic potential: CD57+ NK cells possess superior cytotoxic machinery, including high concentrations of perforin and granzymes A and B. They are more efficient at degranulation and antibody-dependent cellular cytotoxicity (ADCC) than immature subsets.
• Functional deficiency: A reduction in CD57+ populations directly correlates with a diminished capacity for "missing self" recognition and rapid response to infected or malignant cells. In states of chronic immune activation, this depletion may reflect "exhaustion" or a failure of the precursor pool to mature, potentially impairing long-term pathogen clearance.

Bottom line

While a low CD57+ count reliably indicates reduced cytotoxic immune surveillance capacity due to a deficit in mature, highly active NK cells, its specific link to chronic Borrelia exposure is plausible but not consistently supported by clinical evidence. It should be viewed as a general indicator of NK cell maturation status rather than a definitive marker for Lyme disease.